Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

Objective. To investigate the risk factors for hepatic steatosis in chronic hepatitis B (CHB), to determine its correlation with liver necroinflammation and fibrosis and response to peginterferon alpha-2a (PEG-IFNα-2a) antiviral therapy, and to explore the mechanisms underlying the poor antiviral ef...

Full description

Bibliographic Details
Main Authors:	Huiqing Liang, Yaoyu Liu, Xiaoqian Jiang, Xiaoting Zheng, Jinmo Tang, Jiaen Yang, Hongli Zhuang, Penghua Lai, Li Peng, Zhenying Guo, Shanshan Cai, Dan Luo, Lingxia Xu, Qianguo Mao, Shaodong Chen
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2020/1794769

Similar Items

The influence of hepatic steatosis on the success of antiviral therapy for chronic hepatitis C
by: Preveden Tomislav, et al.
Published: (2017-01-01)

Value of direct-acting antivirals combined with PR regimen (PEG-IFN combined with ribavirin) in the new era of antiviral therapy for hepatitis C
by: CHEN Xinyue, et al.
Published: (2017-06-01)

Inhibitory Effect of Gardenoside on Free Fatty Acid-Induced Steatosis in HepG2 Hepatocytes
by: Huiqing Liang, et al.
Published: (2015-11-01)

Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments
by: Munechika Enjoji, et al.
Published: (2012-01-01)

Iron, hepatitis C virus and hepatic steatosis
by: J. A. Solís Herruzo, et al.

The influence of hepatic steatosis to chronic hepatitis C
by: Meng-Hsuan Hsieh, et al.
Published: (2006)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
by: Malcolm M. Wells, et al.
Published: (2016-01-01)

The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease
by: Zhijia Zhou, et al.
Published: (2021-01-01)

PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C.
by: Antoaneta A Markova, et al.
Published: (2014-01-01)

The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV–HCV Coinfection
by: Leigh P. Johnson, et al.
Published: (2020-04-01)

Hepatic steatosis in patients with acromegaly
by: Andreani Koutsou‐Tassopoulou, et al.
Published: (2019-10-01)

Inflammatory Mediators of Hepatic Steatosis
by: Elizabeth Hijona, et al.
Published: (2010-01-01)

Hepatic Steatosis and TNF-?? Signaling
by: Modi, Nita
Published: (2007)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
Published: (2006-04-01)

A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B.
by: Xianqiong Gong, et al.
Published: (2015-01-01)

Morphometric analysis of hepatic steatosis in chronic hepatitis C infection
by: Zubair Alia, et al.
Published: (2009-01-01)

Multiple hepatic pseudotumors: A rare presentation of hepatic steatosis
by: Hirohisa Fujikawa, et al.
Published: (2021-05-01)

The relationship between zinc and hepatic steatosis
by: Emine Türkkan, et al.
Published: (2019-08-01)

The impact of hepatic steatosis on portal hypertension.
by: Georg Semmler, et al.
Published: (2019-01-01)

Hepatic Steatosis: Can herbs cure this?
by: Rabia Rehan, et al.
Published: (2018-03-01)

The Associations of Anthropometric Parameters and Hepatic Steatosis
by: Maryam Ghandehari, et al.
Published: (2020-03-01)

Recent Advances in the Assessment of Hepatic Steatosis
by: V.I. Didenko
Published: (2015-09-01)

Risk Factors for Hepatic Steatosis in Children
by: Yu.M. Stepanov, et al.
Published: (2016-04-01)

Are Steatosis and Steatohepatitis Triggers of Hepatic Fibrogenesis?
by: Yu.M. Stepanov, et al.
Published: (2013-04-01)

Hepatic Steatosis and TNF-α Signaling
by: Modi, Nita
Published: (2007)

Genetic determinants of hepatic steatosis in man
by: Amanda J. Hooper, et al.
Published: (2011-04-01)

Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease
by: Ruifang Zhao, et al.
Published: (2020-05-01)

Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis
by: Lena Seidemann, et al.
Published: (2021-02-01)

Prevalence and clinical features of hepatic steatosis in patients with chronic hepatitis B
by: ZHANG Zhiqiao, et al.
Published: (2015-07-01)

Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial
by: Yan Xu, et al.
Published: (2017-08-01)

Changes in miR-122 and Cholesterol Expression in Chronic Hepatitis C Patients after PegIFN-Alpha/Ribavirin Treatment
by: Malgorzata Sidorkiewicz, et al.
Published: (2020-06-01)

Association between IPS-1 polymorphisms and PEG-IFN treatment response in patients with HBeAg-positive chronic hepatitis B
by: WU Haiqing
Published: (2014-08-01)

Role of PAI-1 in hepatic steatosis and dyslipidemia
by: Joshua A. Levine, et al.
Published: (2021-01-01)

Clinical and Anamnestic Features of Hepatic Steatosis in Children
by: N.Yu. Zavgorodnia, et al.
Published: (2015-11-01)

Hepatic Steatosis as a Marker of Metabolic Dysfunction
by: Elisa Fabbrini, et al.
Published: (2015-06-01)

Hepatic Steatosis and Steatohepatitis Is the Inevitability of Mixed Genesis
by: Yu.M. Stepanov
Published: (2014-11-01)

Autophagy in Hepatic Steatosis: A Structured Review
by: Vitor de Miranda Ramos, et al.
Published: (2021-04-01)

Insulin resistance and steatosis in chronic hepatitis C
by: Mariana V. Machado, et al.
Published: (2009-01-01)

Alcohol and HBV synergistically promote hepatic steatosis
by: Zhan-Ming Li, et al.
Published: (2019-11-01)

The cost of successful antiviral therapy in hepatitis C patients: a comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia
by: Lee AS, et al.
Published: (2017-10-01)